Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease

Wonju Kim, Mi Jung Im, Cheol Hyoung Park, Changjoon Lee, Sukwoo Choi, Bongjune Yoon

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Medium spiny neurons (MSNs) are the major type of neurons found in the striatum. The dendritic spines on these cells contain glutamatergic synaptic contacts between the cortex (or the thalamus) and the striatum. The complexity of the dendritic structure of MSNs may therefore reflect the functional status of the basal ganglia because the striatum is the major input structure in which signals from different regions are integrated. We examined the structural alterations in the dendrites of striatal MSNs in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease (PD). Acute MPTP treatment rapidly damaged dopaminergic neurons and their terminals within the striatum and caused behavioral impairments. However, mice injected with MPTP spontaneously recovered from these behavioral impairments within one week. This recovery was accompanied by the restoration of dendritic structures on MSNs, but the damage to dopaminergic neurons remained extensive. Furthermore, we demonstrated that rasagiline, a monoamine oxidase-B (MAO-B) inhibitor that has been shown to be efficacious for PD, could enhance the dendritic complexity of cultured MSNs. The effect of rasagiline on the spine-like structures of dendrites, however, appears not to require DA availability because the small protrusions of dendrites in cultured MSNs without major source of DA input was similarly changed by rasagiline. Our data suggest that the dendritic structures of striatal MSNs change dynamically, reflecting the progression of motor-related symptoms in PD, and the restoration of functional synapses in the MSNs of PD patients may constitute a clinical target for symptomatic alleviation.

Original languageEnglish
Pages (from-to)95-100
Number of pages6
JournalNeuroscience Letters
Volume557
Issue numberPB
DOIs
Publication statusPublished - 2013 Dec 17

Fingerprint

Corpus Striatum
Neuronal Plasticity
Parkinson Disease
Neurons
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Dendrites
Dopaminergic Neurons
Dendritic Spines
Monoamine Oxidase Inhibitors
Monoamine Oxidase
Basal Ganglia
Thalamus
Synapses
Spine

Keywords

  • Dendritic spine
  • MAO-B inhibitor
  • Medium spiny neuron
  • Parkinson's disease
  • Striatum

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease. / Kim, Wonju; Im, Mi Jung; Park, Cheol Hyoung; Lee, Changjoon; Choi, Sukwoo; Yoon, Bongjune.

In: Neuroscience Letters, Vol. 557, No. PB, 17.12.2013, p. 95-100.

Research output: Contribution to journalArticle

Kim, Wonju ; Im, Mi Jung ; Park, Cheol Hyoung ; Lee, Changjoon ; Choi, Sukwoo ; Yoon, Bongjune. / Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease. In: Neuroscience Letters. 2013 ; Vol. 557, No. PB. pp. 95-100.
@article{adab523eac4e4549859b7a38c3dcb9d1,
title = "Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease",
abstract = "Medium spiny neurons (MSNs) are the major type of neurons found in the striatum. The dendritic spines on these cells contain glutamatergic synaptic contacts between the cortex (or the thalamus) and the striatum. The complexity of the dendritic structure of MSNs may therefore reflect the functional status of the basal ganglia because the striatum is the major input structure in which signals from different regions are integrated. We examined the structural alterations in the dendrites of striatal MSNs in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease (PD). Acute MPTP treatment rapidly damaged dopaminergic neurons and their terminals within the striatum and caused behavioral impairments. However, mice injected with MPTP spontaneously recovered from these behavioral impairments within one week. This recovery was accompanied by the restoration of dendritic structures on MSNs, but the damage to dopaminergic neurons remained extensive. Furthermore, we demonstrated that rasagiline, a monoamine oxidase-B (MAO-B) inhibitor that has been shown to be efficacious for PD, could enhance the dendritic complexity of cultured MSNs. The effect of rasagiline on the spine-like structures of dendrites, however, appears not to require DA availability because the small protrusions of dendrites in cultured MSNs without major source of DA input was similarly changed by rasagiline. Our data suggest that the dendritic structures of striatal MSNs change dynamically, reflecting the progression of motor-related symptoms in PD, and the restoration of functional synapses in the MSNs of PD patients may constitute a clinical target for symptomatic alleviation.",
keywords = "Dendritic spine, MAO-B inhibitor, Medium spiny neuron, Parkinson's disease, Striatum",
author = "Wonju Kim and Im, {Mi Jung} and Park, {Cheol Hyoung} and Changjoon Lee and Sukwoo Choi and Bongjune Yoon",
year = "2013",
month = "12",
day = "17",
doi = "10.1016/j.neulet.2013.10.049",
language = "English",
volume = "557",
pages = "95--100",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "PB",

}

TY - JOUR

T1 - Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson's disease

AU - Kim, Wonju

AU - Im, Mi Jung

AU - Park, Cheol Hyoung

AU - Lee, Changjoon

AU - Choi, Sukwoo

AU - Yoon, Bongjune

PY - 2013/12/17

Y1 - 2013/12/17

N2 - Medium spiny neurons (MSNs) are the major type of neurons found in the striatum. The dendritic spines on these cells contain glutamatergic synaptic contacts between the cortex (or the thalamus) and the striatum. The complexity of the dendritic structure of MSNs may therefore reflect the functional status of the basal ganglia because the striatum is the major input structure in which signals from different regions are integrated. We examined the structural alterations in the dendrites of striatal MSNs in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease (PD). Acute MPTP treatment rapidly damaged dopaminergic neurons and their terminals within the striatum and caused behavioral impairments. However, mice injected with MPTP spontaneously recovered from these behavioral impairments within one week. This recovery was accompanied by the restoration of dendritic structures on MSNs, but the damage to dopaminergic neurons remained extensive. Furthermore, we demonstrated that rasagiline, a monoamine oxidase-B (MAO-B) inhibitor that has been shown to be efficacious for PD, could enhance the dendritic complexity of cultured MSNs. The effect of rasagiline on the spine-like structures of dendrites, however, appears not to require DA availability because the small protrusions of dendrites in cultured MSNs without major source of DA input was similarly changed by rasagiline. Our data suggest that the dendritic structures of striatal MSNs change dynamically, reflecting the progression of motor-related symptoms in PD, and the restoration of functional synapses in the MSNs of PD patients may constitute a clinical target for symptomatic alleviation.

AB - Medium spiny neurons (MSNs) are the major type of neurons found in the striatum. The dendritic spines on these cells contain glutamatergic synaptic contacts between the cortex (or the thalamus) and the striatum. The complexity of the dendritic structure of MSNs may therefore reflect the functional status of the basal ganglia because the striatum is the major input structure in which signals from different regions are integrated. We examined the structural alterations in the dendrites of striatal MSNs in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease (PD). Acute MPTP treatment rapidly damaged dopaminergic neurons and their terminals within the striatum and caused behavioral impairments. However, mice injected with MPTP spontaneously recovered from these behavioral impairments within one week. This recovery was accompanied by the restoration of dendritic structures on MSNs, but the damage to dopaminergic neurons remained extensive. Furthermore, we demonstrated that rasagiline, a monoamine oxidase-B (MAO-B) inhibitor that has been shown to be efficacious for PD, could enhance the dendritic complexity of cultured MSNs. The effect of rasagiline on the spine-like structures of dendrites, however, appears not to require DA availability because the small protrusions of dendrites in cultured MSNs without major source of DA input was similarly changed by rasagiline. Our data suggest that the dendritic structures of striatal MSNs change dynamically, reflecting the progression of motor-related symptoms in PD, and the restoration of functional synapses in the MSNs of PD patients may constitute a clinical target for symptomatic alleviation.

KW - Dendritic spine

KW - MAO-B inhibitor

KW - Medium spiny neuron

KW - Parkinson's disease

KW - Striatum

UR - http://www.scopus.com/inward/record.url?scp=84888065729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888065729&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2013.10.049

DO - 10.1016/j.neulet.2013.10.049

M3 - Article

VL - 557

SP - 95

EP - 100

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - PB

ER -